Schonfeld Strategic Advisors’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $573K | Sell |
17,624
-3,501
| -17% | -$114K | ﹤0.01% | 1422 |
|
|
2025
Q1 | $798K | Buy |
21,125
+725
| +4% | +$27.4K | ﹤0.01% | 1265 |
|
|
2024
Q4 | $1.67M | Sell |
20,400
-60,610
| -75% | -$4.96M | 0.01% | 850 |
|
|
2024
Q3 | $9.26M | Buy |
81,010
+56,222
| +227% | +$6.42M | 0.06% | 258 |
|
|
2024
Q2 | $1.87M | Sell |
24,788
-26,812
| -52% | -$2.02M | 0.01% | 826 |
|
|
2024
Q1 | $3.52M | Sell |
51,600
-81,688
| -61% | -$5.58M | 0.02% | 639 |
|
|
2023
Q4 | $8.37M | Sell |
133,288
-132,733
| -50% | -$8.34M | 0.06% | 365 |
|
|
2023
Q3 | $13.6M | Buy |
266,021
+23,943
| +10% | +$1.22M | 0.11% | 244 |
|
|
2023
Q2 | $12.1M | Buy |
242,078
+150,864
| +165% | +$7.53M | 0.1% | 301 |
|
|
2023
Q1 | $3.42M | Sell |
91,214
-65,909
| -42% | -$2.47M | 0.03% | 542 |
|
|
2022
Q4 | $7.53M | Buy |
157,123
+134,144
| +584% | +$6.43M | 0.06% | 372 |
|
|
2022
Q3 | $551K | Buy |
+22,979
| New | +$551K | ﹤0.01% | 1655 |
|